Stay updated on Denosumab+Nivolumab in Stage IV NSCLC Clinical Trial

Sign up to get notified when there's something new on the Denosumab+Nivolumab in Stage IV NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Denosumab+Nivolumab in Stage IV NSCLC Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    1%
    Check dated 2025-02-24T21:55:42.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The page has been updated to reflect the current status of the DENIVOS study, including new dates and the removal of outdated information regarding its status and last updates.
    Difference
    3%
    Check dated 2025-02-17T17:39:33.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    The page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for the Help Desk.
    Difference
    1%
    Check dated 2025-02-10T13:56:02.000Z thumbnail image
  7. Check
    50 days ago
    Change Detected
    Summary
    The website has been updated from version v2.14.1 to v2.14.2.
    Difference
    0.1%
    Check dated 2025-02-03T10:09:07.000Z thumbnail image
  8. Check
    64 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.0 to 2.14.1.
    Difference
    0.1%
    Check dated 2025-01-20T01:34:01.000Z thumbnail image
  9. Check
    71 days ago
    Change Detected
    Summary
    The website has updated the intervention type information to include a verified status from July 2022 by Centre Hospitalier Annecy Genevois, while also upgrading to revision v2.14.0, following the removal of the previous intervention type in revision v2.13.3.
    Difference
    0.6%
    Check dated 2025-01-12T21:30:16.000Z thumbnail image

Stay in the know with updates to Denosumab+Nivolumab in Stage IV NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Denosumab+Nivolumab in Stage IV NSCLC Clinical Trial page.